{"title":"Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience.","authors":"N Begic, Z Begic, E Begic","doi":"10.2478/bjmg-2021-0002","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0002","url":null,"abstract":"<p><p>The aim of this paper is to present a patient with the Smith-Lemli-Opitz syndrome (SLOS), with an overview of the modality of diagnosis, and the treatment of the patient. Exome analysis showed two variants in exon 6 of the 7-dehydrocholesterol reductase (<i>DHCR7</i>) gene have been determined: missense variant <i>1)</i> NM_001360.2: c.470T>C (p.Leu157Pro) and <i>2)</i> nonsense variant c.452G>A (W151*). Therefore the <i>DHCR7</i> genotype of the patient is NM_001360.2: c.[470T>C; c.452G>A]. The proband, aged 6 years, has global developmental retardation with missing contact gaze and lacking motor development for her age and with peripheral spastic-enhanced muscle tone, and is under the supervision of children neurologists, gastroenterologists, nephrologists and cardiologists.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/e2/bjmg-24-099.PMC8366476.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dual Effect of the <i>GHRL</i> Gene Variant in the Molecular Pathogenesis of Obesity.","authors":"E Becer, M C Ergoren","doi":"10.2478/bjmg-2021-0011","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0011","url":null,"abstract":"<p><p>Obesity is as a global health problem due to its interaction with complex chronic disorders such as cardiovascular disorders, type 2 diabetes mellitus (T2DM) and cancer. Despite the fact that pathogenesis of obesity is not yet clearly understood, it is associated with a combination of psychological, environmental and various genetic factors. Here, employing a case-control design, we aimed to examine the effects of the <i>GHRL</i> c.152C>T (p.Arg51Gln) (rs34911341) and c.214G>T (p.Leu72Met) (rs696217) markers on susceptibility to obesity in a Turkish-Cypriot population, as well as to evaluate whether these markers affect biochemical parameters and show their putative functional consequences. This study involved 211 Turkish-Cypriot subjects (106 obese and 95 non obese). Genotyping for the <i>GHRL</i> gene polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Our results indicate that the <i>GHRL</i> Leu72Met polymorphism was found to be significantly higher in obese patients, with respect to genotypic (<i>p</i> = 0.0012) and allelic (<i>p</i> = 0.0005) frequencies. Strikingly, the rs696217 GT genotype (heterozygous) had significantly lower serum high-density lipoprotein cholesterol (HDL-C) (<i>p</i> = 0.015) than GG (wild type) genotypes. Overall, Leu72Met susceptibility variant may be considered as risk and crucial marker for both obesity and cholesterol metabolism in the community of Turkish-Cypriots. Thus, the dual effect of the <i>GHRL</i> gene Leu72Met variant may be used for clinical diagnosis.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/83/bjmg-24-027.PMC8366472.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H Ozkayalar, M C Ergoren, G Tuncel, S Kurt, E Cevik, S Ozemri Sag, B Yilmaz Ozguven, F Kabukcuoglu, G Mocan, Ş G Temel
{"title":"Mutation Status and Immunohistochemical Correlation of <i>EGFR</i> Mutations in Gastrointestinal Stromal Tumors.","authors":"H Ozkayalar, M C Ergoren, G Tuncel, S Kurt, E Cevik, S Ozemri Sag, B Yilmaz Ozguven, F Kabukcuoglu, G Mocan, Ş G Temel","doi":"10.2478/bjmg-2021-0006","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0006","url":null,"abstract":"<p><p>Being one of the leading causes of cancer deaths worldwide and their resistance to conventional treatment methods, made gastrointestinal stromal tumors (GISTs) one of the hot topics in medical research areas in the past decade. To investigate molecular alterations underlying the tumor is of great importance to be able to develop new, targeted treatment options. In this study, GIST samples obtained from 40 Turkish patients were analyzed for actionable epidermal growth factor receptor (<i>EGFR</i>) mutations that are related to treatment regimes in non small cell lung cancer (NSCLC) to understand whether <i>EGFR</i> expression is altered in GISTs. Established alterations in <i>EGFR</i> can make the use of tyrosine kinase inhibitors possible, which are currently used in cancer therapy, especially in NSCLC. Our results indicated that <i>EGFR</i> mutations are rare in GISTs. Further research is needed to sequence whole coding regions of the gene to investigate new actionable mutations in <i>EGFR</i> in an increased sample size.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8d/b5/bjmg-24-067.PMC8366477.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Familial Atypical Hemolytic Uremic Syndrome with Positive p.S1191L (c.3572C>T) Mutation on the <i>CFH</i> Gene: A Single-center Experience.","authors":"F Ersoy Dursun, G Yesil, G Sasak, H Dursin","doi":"10.2478/bjmg-2021-0007","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0007","url":null,"abstract":"<p><p>The atypical hemolytic uremic syndrome (aHUS) is characterized by thrombocytopenia, microangiopathic hemolytic anemia and acute kidney injury (AKI), which can exhibit a poor prognosis. Complement factor H (<i>CFH</i>) gene mutations play a key role in this disease, which may be sporadic or familial. We studied 13 people from the same family, investigated for gene mutations of the familial aHUS after a family member presented to our emergency clinic with the aHUS and reported a family history of chronic renal failure. The p.S1191L mutation on the <i>CFH</i> gene was heterozygous in six people from the patient's family with the aHUS. One of these family members is our patient with acute kidney injury, and the other two are followed at the Nephrology Clinic, Medeniyat University, Goztepe Training and Research Hospital, Istanbul, Turkey, due to chronic renal failure. The other three family members showed no evidence of renal failure. The index case had a history of six sibling deaths; three died of chronic renal failure. Plasmapheresis and fresh frozen plasma treatment were administered to our patient. When the patient showed no response to this treatment, eculizumab (ECZ) therapy was started. The study demonstrated that thorough family history should be taken in patients with the aHUS. These patients may have the familial type of the disease, and they should be screened genetically. Eculizumab should be the first choice in the treatment with plasmapheresis. It should be kept in mind that the use of ECZ as prophylaxis in posttransplant therapy is extremely important for preventing rejection.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/f9/bjmg-24-081.PMC8366473.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Duplication of Chromosome 16p13.11-p12.3 with Different Expressions in the Same Family.","authors":"N Pop-Jordanova, T Zorcec, E Sukarova-Angelovska","doi":"10.2478/bjmg-2021-0010","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0010","url":null,"abstract":"<p><p>The knowledge about genetic involvement in neurodevelopmental disorders, and especially in autism, is currently rising. To date, more than 100 gene mutations related to autistic syndromes have been described. Some disorders that affect multiple family members are caused by gene mutations, which can be inherited. Recently, array comparative genomic hybridization (aCGH) has identified sub microscopic deletions and duplications as a common cause of mental retardation and autism. In this article we report the occurrence of the same genetic finding (chromosome 16p13.11-p12.3 duplication) in a family with four small children, where two older siblings manifested a global neurodevelopmental delay associated with an autism spectrum disorder (ASD), but younger twin brothers with the same mutation, have typical development. Genetic analysis showed that the chromosomal duplication was inherited from the father, in which phenotype and functioning are quite typical. As is known, the duplication can pass from parents to children. The 16p13.11 micro duplication has been implicated in several neurodevelopmental and behavioral disorders and is characterized by variable expressivity and incomplete penetrance.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/05/bjmg-24-089.PMC8366479.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L Aidinidou, A Chatzikyriakidou, A Giannopoulos, V Karpa, I Tzimou, E Aidinidou, L Fidani
{"title":"Association of <i>NFKB1</i>, <i>NKX2-5</i>, <i>GATA4</i> and <i>RANKL</i> Gene Polymorphisms with Sporadic Congenital Heart Disease in Greek Patients.","authors":"L Aidinidou, A Chatzikyriakidou, A Giannopoulos, V Karpa, I Tzimou, E Aidinidou, L Fidani","doi":"10.2478/bjmg-2021-0014","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0014","url":null,"abstract":"<p><p>Congenital heart disease (CHD) is a group of structural defects of the heart and the great vessels, and one of the leading causes of death among infants and young adults. Several gene variants are involved in diverse mechanisms of cardiac and vessel development and could thus be considered candidate mutated genes for a congenital heart defect or a specific variant could predispose a person to CHD. In the present study, variants in four such genes are investigated for the first time in a group of young Greek CHD patients: the <i>NFKB1</i> gene polymorphism (-94ins/ delATTG), rs28362491, <i>NKX2-5</i> gene polymorphism rs2277923, <i>GATA4</i> gene polymorphism rs11785481 and <i>RANKL</i> gene polymorphism <i>rs4531631</i>. A total of 43 CHD patients and 100 healthy adults were included in the study. The polymerase chain reaction-restriction fragment length polymorphism (PRC-RFLP) method was used to genotype the aforementioned polymorphisms of <i>NFKB1</i>, <i>NKX2-5</i>, <i>GATA4</i> and <i>RANKL</i>. The association analysis identified that there was a protective association between CHD and the A allele of rs2277923 polymorphism (<i>p</i> = 0.004). The D allele of the rs28362491 polymorphism is also a likely risk factor for causing CHD (<i>p</i> = 0.006). The differences of the rs4531631 and rs11785481 variant contribution had no statistical significance between the groups (<i>p</i> >0.05). In conclusion, our results revealed that the rs28362491 and rs2277923 gene polymorphisms, but not the rs4531631 and rs11785481 polymorphisms, may contribute to CHD risk in a cohort of Greek CHD patients.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/0f/bjmg-24-015.PMC8366470.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39357171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Case of Glycogen Storage Disease Type 1a Mimicking Familial Chylomicronemia Syndrome.","authors":"A Olgac, I Okur, G Biberoğlu, F S Ezgü, L Tümer","doi":"10.2478/bjmg-2021-0013","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0013","url":null,"abstract":"<p><p>Glycogen storage disease type 1a (GSD1a) is an autosomal recessively inherited inborn error of metabolism caused by a mutation in the <i>G6PC</i> gene, which encodes the catalytic subunit of glucose-6-phosphatase-α (G6Pase-α) enzyme. This enzyme plays a role in the final step of gluconeogenesis and glycogenolysis. Patients carrying GSD1a show growth retardation, hypoglycemia, hepatomegaly, hepatic steatosis, hyperlipidemia, hyperuricemia and lactic acidemia. Long-term symptoms include gouty arthritis and uric acid stones, osteoporosis, renal failure, intestinal impairment, cirrhosis and hepatic adenomas, and eventually, hepatocellular carcinoma. Hyperlipidemia is the indicator of poor metabolic control in GSD1a. Patients with variable levels of triglycerides (TGs) have been reported in the literature. We present a case of GSD1a that presented with severe hypertriglyceridemia (HTG) mimicking familial chylomicronemia syndrome.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/c3/bjmg-24-103.PMC8366469.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Mladenova, T Todorov, L Grozdanova, V Mitev, A Todorova
{"title":"Novel Mutation in the <i>COL11A1</i> Gene Causing Marshall-Stickler Syndrome in Three Generations of a Bulgarian Family.","authors":"M Mladenova, T Todorov, L Grozdanova, V Mitev, A Todorova","doi":"10.2478/bjmg-2021-0001","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0001","url":null,"abstract":"<p><p>Here we report the first familial case spread through at least three generations, genetically verified cases of Marshall-Stickler syndrome in Bulgaria. The proband, a 2-year-old girl, has craniofacial dysplasia, ocular hypertelorism, small saddle nose with a flat bridge and midface hypoplasia. The pedigree of the proband's family showed that her father has the same clinical manifestations of the disease. In addition, her father presented with a tall, thin stature and mild hearing loss, manifested with aging. The same dysmorphological symptoms were presented by the paternal grandfather. Both patients, the 2-year-old girl and her father, have been diagnosed to carry Marshall-Stickler syndrome. The <i>COL2A1</i> gene tested negative in the family. Based on the higher percentage of mutations in the <i>COL2A1</i> gene, we analyzed this gene as the first target in the family. The <i>COL2A1</i> gene tested negative, and we sequenced the gene further. A novel splice site mutation c.3474+1G>A was found in intron 44. This variant is related to the clinical presentation in the patient and her father. The c.3474+1G>A mutation results in altered splicing affects at the donor splice site of intron 44, which most probably gives a nonfunctional protein. The variant affects the major triple-helical domain that represents a mutation hot-spot for the gene.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/57/bjmg-24-095.PMC8366474.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T D Lao, P K Truong, H H Thieu, D H Nguyen, M T Nguyen, Tah Le
{"title":"Simultaneously Both Expression of <i>LMP-1</i> and Methylation of <i>E-cadherin</i>: Molecular Biomarker in Stage IV of Nasopharyngeal Carcinoma Patients.","authors":"T D Lao, P K Truong, H H Thieu, D H Nguyen, M T Nguyen, Tah Le","doi":"10.2478/bjmg-2021-0005","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0005","url":null,"abstract":"<p><p>The phenome of <i>E-cadherin</i> gene methylation and the expression of latent membrane protein 1 (<i>LMP-1</i>) gene are associated with nasopharyngeal carcinoma (NPC). In order to determine whether cooperative <i>LMP-1</i> expression or methylation of <i>E-cadherin</i> could serve as the potential molecule biomarker target for diagnosis and therapy of NPC, a case-control study including 93 NPC biopsy samples and 100 non cancerous nasopharyngeal swab samples were examined, as well as the strength of association among them by the quantitative polymerase chain reaction (qPCR) and nested-methylation-specific PCR methods. The significantly higher frequency of <i>LMP-1</i> expression and <i>E-cadherin</i> methylation in NPC biopsy samples, accounting for 76.34 and 73.12%, respectively, compared to non cancerous samples, accounting for 0.00 and 30.00%, respectively, were observed. The significant correlation between the <i>LMP-1</i> expression and <i>E-cadherin</i> methylation in NPC samples was reported. In detail, in the stage IV of NPC, in case of <i>LMP-1</i>-positive samples, 35 of 37 samples (accounting for 94.60%) were positive for methylation of <i>E-cadherin</i>. It was demonstrated that cooperative <i>LMP-1</i> expression and <i>E-cadherin</i> gene methylation could serve as a molecular biomarker in NPC.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/02/66/bjmg-24-057.PMC8366468.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N G Kirnap, N B Tutuncu, Y Yalcin, Hpb Cebi, T Tutuncu, A Nar, H Verdi, F B Atac
{"title":"GA Genotype of the Arg280His Polymorphism on The <i>XRCC1</i> Gene: Genetic Susceptibility Genotype in Differentiated Thyroid Carcinomas?","authors":"N G Kirnap, N B Tutuncu, Y Yalcin, Hpb Cebi, T Tutuncu, A Nar, H Verdi, F B Atac","doi":"10.2478/bjmg-2021-0003","DOIUrl":"https://doi.org/10.2478/bjmg-2021-0003","url":null,"abstract":"<p><p>Differentiated thyroid carcinomas (DTC) are the most common form of endocrine malignancies. The role of genetic variations in the development of papillary thyroid carcinoma (PTC) is approximately 60.0-70.0%. The X-ray repair cross-complementing group 1 (<i>XRCC1</i>) protein has an important role in DNA repair mechanisms and genomic polymorphisms of <i>XRCC1</i> gene affect the function of the protein. In the present case-control study, we aimed to compare the genotype frequency distributions of <i>XRCC1</i> single nucleotide polymorphisms (SNPs) in terms of the presence of other risk factors (Hashimoto's thyroiditis, smoking, obesity, radiation exposure) in patients with thyroid nodules who had fine-needle aspiration biopsy (FNAB) and/or thyroid surgery due to thyroid cancer. The genotype frequency distributions of three common <i>XRCC1</i> SNPs (Arg194Trp, Arg399Gln, Arg280His) were compared to those with DTC (<i>n</i> = 228), benign thyroid nodules (BTN, <i>n</i> = 100) and healthy controls (<i>n</i> = 93) in terms of certain pre defined risk factors such as the presence of Hashimoto's thyroiditis, smoking, obesity, a family history of thyroid cancer and radiation exposure. The frequency of the GA genotype of Arg280His in DTC cases was found to be higher than in those with BTN and the healthy control group (<i>p</i> <0.001). The DTC group had the lowest frequency of AA genotype of Arg280His (35.5%, <i>p</i> <0.001). Among those with a family history of thyroid cancer, 78.9% had a GA genotype and 21.1% had the AA genotype of Arg280His (<i>p</i> = 0.004). The Arg280His GA genotype was more common in DTC than in cancer-free controls. The GA genotype frequency was also high in DTC cases with a family history of thyroid cancer.</p>","PeriodicalId":55403,"journal":{"name":"Balkan Journal of Medical Genetics","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/c2/bjmg-24-073.PMC8366467.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39356108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}